Key facts
- GUTOLOGY’s last known valuation is $12.5M (Jan 2025).
- It has raised $3.0M; the latest was Later Stage VC ($2.3M) in Jan 2025.
- Notable investors include Mercia Ventures, Active Partners, Rigby Technology Investments, Bell Partnership, Nodes Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for GUTOLOGY
- ·The full record, as it builds
Funding rounds
No funding rounds for GUTOLOGY are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GUTOLOGY
Operator of a functional medicine firm intended for mouth and gut care. The company offers fluoride-free toothpaste formulated with biomimetic hydroxyapatite and postbiotics for adults and kids, along with offering mouthwashes and other care accessories. enabling people to take a daily care routine that supports the beneficial bacteria in their mouth.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Alcester, United Kingdom
- Founded
- 2020
- Employees
- 8
- Website
- gutology.co.uk/
- Ownership
- Privately Held (backing)
GUTOLOGY doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GUTOLOGY shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GUTOLOGY in its N-PORT filings yet. We sweep new filings monthly.